Dawn Svoronos's Net Worth

$3.81 Million

Estimate Recalculated Jun 20, 2024 03:54PM EST

Who is Dawn Svoronos?

Dawn Svoronos has an estimated net worth of $3.81 Million. This is based on reported shares across multiple companies, which include ACELYRIN, Inc., Xenon Pharmaceuticals Inc., Global Blood Therapeutics, Inc., PTC THERAPEUTICS, INC., Adverum Biotechnologies, Inc., MEDIVATION, INC., and ENDOCYTE INC.

SEC CIK

Dawn Svoronos's CIK is 0001574579

Past Insider Trading and Trends

2022 was Dawn Svoronos's most active year for acquiring shares with 8 total transactions. Dawn Svoronos's most active month to acquire stocks was the month of May. 2022 was Dawn Svoronos's most active year for disposing of shares, totalling 11 transactions. Dawn Svoronos's most active month to dispose stocks was the month of May. 2017 saw Dawn Svoronos paying a total of $337,230.00 for 37,000 shares, this is the most they've acquired in one year. In 2023 Dawn Svoronos cashed out on 203,693 shares for a total of $967,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ACELYRIN, Inc. (SLRN) Snapshot price: $7.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
∞
15K
$18.00
$270,000.00
15K
May 9
Form 4
—
0
—
—
0
May 4
Form 3
—
0
—
—
0
No matching records found

Xenon Pharmaceuticals Inc. (XENE) Snapshot price: $47.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 5
Form 4
-50.00%
-25.00K
$38.70
-$967,500.00
25K
Aug 24
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 28
Form 3
—
0
—
—
0
No matching records found

Global Blood Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-5.38K
—
—
0
Oct 5
Form 4
-26.19%
-1.91K
$27.24
-$51,982.70
5.38K
Scheduled
Jun 21
Form 4
+97.72%
3.6K
—
—
7.28K
Jun 14
Form 4
+63.30%
1.43K
$36.54
-$58,792.86
3.68K
Scheduled
Jun 17 - Jun 18
Form 4
∞
2.26K
$63.94
-$162,663.28
2.26K
Scheduled
Jun 17 - Jun 19
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Dec 19
Form 3
—
0
—
—
0
No matching records found

PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $26.79

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.48%
-738.00
$27.20
-$20,074.34
29.02K
Jun 9
Form 4
+9.94%
2.69K
$38.53
-$19,647.75
29.75K
Jan 7
Form 4
-1.33%
-365.00
$41.89
-$15,288.02
27.07K
Jun 9
Form 4
-1.81%
-506.00
$56.96
-$28,819.74
27.43K
Feb 1
Form 4
+6.28%
1.65K
—
—
27.94K
Jan 6
Form 4
-1.37%
-364.00
$48.36
-$17,603.04
26.29K
Jun 11
Form 4
+6.60%
1.65K
—
—
26.65K
Jan 29
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
25K
$13.49
$337,230.00
25K
May 23
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 10
Form 3
—
0
—
—
0
No matching records found

Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $2.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 10
Form 4
+150.00%
30K
$0.85
$25,578.00
50K
May 16
Form 4
—
0
—
—
0
May 12
Form 4
∞
20K
$10.02
$200,338.00
20K
Mar 31
Form 4
—
0
—
—
0
Dec 9
Form 3
—
0
—
—
0
No matching records found